Lymphoma, Non-Hodgkin: all 2,043 studies
Page 1 of 21. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.
- Phase 1 Study of huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ CancersNot yet recruitingNCT07891468Phase 1
- Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.Not yet recruitingNCT07883941Phase 1
- BEX101 in B-cell Non-Hodgkin's LymphomaRecruitingNCT07882641Phase 1/2
- Study of JMBI-001 in Patients With MYC-Positive Advanced CancersRecruitingNCT07864701Phase 1/2
- Positron Emission Tomography (PET) Imaging of Chemotherapy-Induced CardiotoxicityNot yet recruitingNCT07838649Phase 1
- SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin LymphomaNot yet recruitingNCT07819188Phase 1/2
- New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman DiseaseRecruitingNCT07793006Not applicable
- BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple MyelomaNot yet recruitingNCT07771361Phase 2
- Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin LymphomaRecruitingNCT07763210Phase 2
- Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)RecruitingNCT07750886
- A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell MalignanciesRecruitingNCT07735533Phase 1/2
- Clinical Study of XNW5004 Combined With CHOP/CHOEP in the Treatment of Untreated Peripheral T-Cell LymphomaRecruitingNCT07730515Phase 1/2
- A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin LymphomasNot yet recruitingNCT07713459Phase 2
- Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic MalignanciesNot yet recruitingNCT07710781Not applicable
- BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Hematologic MalignanciesNot yet recruitingNCT07679919Phase 1
- Toxin Exposure and Immune Dysregulation in Non-Hodgkin LymphomaRecruitingNCT07652580
- A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After ChemotherapyRecruitingNCT07628738Phase 2
- A Phase I Study of JLM019 InjectionRecruitingNCT07623850Phase 1
- Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMARecruitingNCT07620314Phase 1
- Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin LymphomaNot yet recruitingNCT07614035
- A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLNot yet recruitingNCT07607925Phase 1/2
- JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaRecruitingNCT07603479Phase 1
- Epcoritamab in Combination With R-CHOP for Patients With Aggressive Non-Hodgkin LymphomaNot yet recruitingNCT07588698Phase 2
- A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin LymphomaRecruitingNCT07582432Phase 3
- Frontline Risk-Adapted Optimization of Novel Targeted Immunotherapy Evaluation in High-Risk MCLNot yet recruitingNCT07569965Phase 2
- Cord Blood Transplantation in Children and Young Adults With Blood CancerRecruitingNCT07566377Phase 2
- AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.RecruitingNCT07546188
- A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)RecruitingNCT07519772Phase 1/2
- Study of ALA-101 in Patients With CD19 Positive Non-Hodgkin Lymphoma and Leukemia.Not yet recruitingNCT07518329Phase 1
- NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)RecruitingNCT07502118Phase 2/3
- Radiation, Oral Vancomycin, and CAR-T for B-Cell LymphomasRecruitingNCT07478848Phase 1
- eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell TransplantationRecruitingNCT07469592Not applicable
- PIC1 Injection Therapy for Relapsed/Refractory B-NHLRecruitingNCT07456371Phase 1
- Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsRecruitingNCT07410494Phase 1/2
- High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin LymphomaNot yet recruitingNCT07366450Not applicable
- PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGERecruitingNCT07313943
- Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid MalignanciesRecruitingNCT07312630Early Phase 1
- A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid MalignanciesRecruitingNCT07308132Phase 1
- Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable
- Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid MalignanciesRecruitingNCT07284927Phase 1
- Amping up With PemJAKRecruitingNCT07283822Phase 2
- KSV01 Injection for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaRecruitingNCT07260812Phase 1
- Prophylactic DLI-X for Leukemia Relapse After HCTNot yet recruitingNCT07254793Phase 1
- A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell TherapyRecruitingNCT07249528
- A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersRecruitingNCT07226843Phase 1
- Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)RecruitingNCT07225439Phase 1
- SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin LymphomasRecruitingNCT07222631Phase 1/2
- Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)RecruitingNCT07202052Phase 2/3
- A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesRecruitingNCT07195916Phase 1
- Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHLRecruitingNCT07195799Phase 2
- A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyRecruitingNCT07188558Phase 3
- Mozobil for Autologous Hematopoietic Stem Cell TransplantationRecruitingNCT07188090Phase 2
- Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)Not yet recruitingNCT07166549Phase 1
- Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell LymphomaNot yet recruitingNCT07159906Phase 1/2
- A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaRecruitingNCT07123454Phase 1/2
- NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's LymphomaRecruitingNCT07114367Phase 1
- An Open-label, Single-arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of OriV508 Injection in Treating Relapsed/Refractory Hematological MalignanciesRecruitingNCT07101705Early Phase 1
- A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )RecruitingNCT07101328Phase 1
- TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasRecruitingNCT07082803Phase 1
- NT-I7 (Efineptakin Alfa), a Long-acting Human IL-7, Post-Axicabtagene Ciloleucel or Post-Lisocabtagene Maraleucel in Subjects With Relapsed/Refractory Large B-cell LymphomaRecruitingNCT07052305Phase 1
- A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )Not yet recruitingNCT07032324Phase 1
- JWCAR239 in Patients With B Cell Non-Hodgkin LymphomaNot yet recruitingNCT07024147Phase 1
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantRecruitingNCT07020533Phase 1
- Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic MalignanciesRecruitingNCT07016165Phase 4
- A Study to Evaluate the Safety and Clinical Efficacy of STR-P004Not yet recruitingNCT07003178Early Phase 1
- Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3ANot yet recruitingNCT06961500Phase 2
- Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND TrialRecruitingNCT06923397Not applicable
- A Study of Carmustine With and Without Ethanol in Subjects With LymphomaRecruitingNCT06915246Phase 2
- A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaRecruitingNCT06876662Phase 4
- A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibRecruitingNCT06876649Phase 4
- GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHLRecruitingNCT06875063Phase 1
- Pre-malignant States to Hematologic Malignancies in FirefightersRecruitingNCT06870760
- A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCLRecruitingNCT06854653Phase 2
- Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin LymphomaNot yet recruitingNCT06845241Phase 1/2
- Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCTRecruitingNCT06839456Phase 1/2
- A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaRecruitingNCT06822868Phase 1
- Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLRecruitingNCT06806033Phase 2
- Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological MalignanciesRecruitingNCT06801002Phase 1
- A Rollover Study for Continued Study Treatment and Ongoing Safety MonitoringEnrolling by invitationNCT06788509Phase 1
- A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological TumorsRecruitingNCT06783816Not applicable
- IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCLRecruitingNCT06768905Phase 1/2
- Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Young Adults with HemoblastosisRecruitingNCT06756152Phase 2/3
- Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced LymphomaRecruitingNCT06755450Phase 1
- Allo-HSCT vs ASCT in Adult T-LBLNot yet recruitingNCT06741813Not applicable
- A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin LymphomaRecruitingNCT06734871Phase 1
- A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin LymphomaRecruitingNCT06725524Phase 1
- An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative DisordersNot yet recruitingNCT06721598
- Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.Not yet recruitingNCT06720701
- Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r B-NHL Clinical ResearchRecruitingNCT06716164Early Phase 1
- To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)RecruitingNCT06698484Phase 2
- An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's LymphomaRecruitingNCT06693973Early Phase 1
- Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma PatientsNot yet recruitingNCT06665737Phase 4
- High-dose Methotrexate Combined with Thiotepa and Zanubrutinib in the Treatment of Newly Diagnosed PCNSL (MTZ)Not yet recruitingNCT06646211Phase 2
- One Trial to Evaluate the Safety, Tolerability and Efficacy of JCXH-213 in Patients With r/r B-NHLRecruitingNCT06618313Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- A Real-World Study on Extranodal LymphomaNot yet recruitingNCT06573099
- Epco, Zanu, Ritux for R/R FL or MZLRecruitingNCT06563596Phase 2
- MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin LymphomaNot yet recruitingNCT06557330Phase 2
- Emapalumab Prevention of CAR-T Cell Associated ToxicitiesRecruitingNCT06550141Phase 2
- SynKIR-310 for Relapsed/Refractory B-NHLRecruitingNCT06544265Phase 1